{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:14:14Z","timestamp":1782890054822,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100024077","name":"University of Cordoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejso.2023.07.004","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:15:17Z","timestamp":1689041717000},"page":"106978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I\/II controlled trial"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-079X","authenticated-orcid":false,"given":"A.","family":"Pontes-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0187-7667","authenticated-orcid":false,"given":"A.","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-7128","authenticated-orcid":false,"given":"L.","family":"Rodr\u00edguez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Valenzuela-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4825-1864","authenticated-orcid":false,"given":"B.","family":"Rufi\u00e1n-And\u00fajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"S\u00e1nchez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casado-Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gordon-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rufi\u00e1n-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"V\u00e1zquez-Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romero-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-3009","authenticated-orcid":false,"given":"A.","family":"Arjona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2023.07.004_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","article-title":"Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis","volume":"14","author":"Sugarbaker","year":"1998","journal-title":"Semin Surg Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2023.07.004_bib2","first-page":"1363","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2023.07.004_bib3","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis from colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2023.07.004_bib4","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2023.07.004_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/bjs.10716","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin","volume":"105","author":"Delhorme","year":"2018","journal-title":"BJS"},{"issue":"5","key":"10.1016\/j.ejso.2023.07.004_bib6","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Joseph","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2023.07.004_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/02656736.2018.1423708","article-title":"Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy","volume":"34","author":"Arjona-Sanchez","year":"2018","journal-title":"Int J Hyperther"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2023.07.004_bib8","article-title":"Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality","volume":"20","author":"Halkia","year":"2015","journal-title":"J\u00a0BUON"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.004_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.23736\/S0026-4733.18.07649-6","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes","volume":"74","author":"Robella","year":"2019","journal-title":"Minerva Chir"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.004_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","article-title":"Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2023.07.004_bib11","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1007\/s00464-013-2823-9","article-title":"Common uses and cited complications of energy in surgery","volume":"27","author":"Sankaranarayanan","year":"2013","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2023.07.004_bib12","first-page":"35","article-title":"Comparative thermal effects of J-plasma\u00ae, monopolar, argon, and laser electrosurgery in a porcine tissue model","volume":"34","author":"Masghati","year":"2019","journal-title":"Surg Technol Int"},{"issue":"9","key":"10.1016\/j.ejso.2023.07.004_bib13","first-page":"1022","article-title":"Pathologic analysis of tissue destruction with neutral argon plasma","volume":"24","author":"Madhuri","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2023.07.004_bib14","first-page":"1326","article-title":"Pathologic analysis of ex\u00a0vivo plasma energy tumour destruction in patients with ovarian or peritoneal cancer","volume":"20","author":"Sonoda","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2023.07.004_bib15","first-page":"46","article-title":"Neutral argon plasma in Gynaecologic oncology surgery","volume":"11","author":"Madhuri","year":"2016","journal-title":"Gyn Cancer"},{"issue":"SUPPL. 1","key":"10.1016\/j.ejso.2023.07.004_bib16","article-title":"Comparison between resection, bipolar coagulation and PlasmaJet: a preliminary animal study","volume":"7","author":"Bourdel","year":"2010","journal-title":"Gynaecological Surgery"},{"key":"10.1016\/j.ejso.2023.07.004_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12885-019-5275-3","article-title":"Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in The Netherlands","volume":"19","author":"Nieuwenhuyzen-de Boer","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2023.07.004_bib18","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1245\/s10434-022-11827-3","article-title":"ASO author reflections: the PlasmaJet\u00ae device contributes to an increase in the number of complete cytoreductive surgeries for ovarian cancer patients","volume":"8","author":"Nieuwenhuyzen-de Boer","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2023.07.004_bib19","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1245\/s10434-022-11763-2","article-title":"Adjuvant use of PlasmaJet device during cytoreductive surgery for advanced-stage ovarian cancer: results of the PlaComOv-study, a randomized controlled trial in The Netherlands","volume":"29","author":"Nieuwenhuyzen-de Boer","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.004_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1553350620908383","article-title":"The emerging role of neutral argon plasma (PlasmaJet) in the treatment of advanced stage ovarian cancer: a systematic review","volume":"27","author":"Prodromidou","year":"2020","journal-title":"Surg Innovat"},{"key":"10.1016\/j.ejso.2023.07.004_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/2041-210X.12504","article-title":"simr: an R package for power analysis of generalised linear mixed models by simulation","author":"Green","year":"2016","journal-title":"Methods Ecol Evol"},{"issue":"2","key":"10.1016\/j.ejso.2023.07.004_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inf"},{"key":"10.1016\/j.ejso.2023.07.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inf"},{"key":"10.1016\/j.ejso.2023.07.004_bib24","first-page":"214","article-title":"Simultaneous optimization of several response variables","volume":"12","author":"Derringer","year":"1980","journal-title":"J\u00a0Qual Technol"},{"key":"10.1016\/j.ejso.2023.07.004_bib25","author":"Anderson"},{"issue":"1","key":"10.1016\/j.ejso.2023.07.004_bib26","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Software"},{"key":"10.1016\/j.ejso.2023.07.004_bib27","article-title":"An\u00e1lisis y Dise\u00f1o de Experimentos","author":"Pulido","year":"2012","journal-title":"SERBIULA"},{"key":"10.1016\/j.ejso.2023.07.004_bib28","first-page":"494","article-title":"The desirability function","volume":"4","author":"Harrington","year":"1965","journal-title":"Ind Qual Control"},{"key":"10.1016\/j.ejso.2023.07.004_bib29","unstructured":"Bratislava, Slovakia: Social policy Institute. https:\/\/CRAN.R-project.org\/package=stargazer."},{"key":"10.1016\/j.ejso.2023.07.004_bib30","author":"Kuhn"},{"issue":"13","key":"10.1016\/j.ejso.2023.07.004_bib31","first-page":"1","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J\u00a0Stat Software"},{"key":"10.1016\/j.ejso.2023.07.004_bib32","author":"Lele"},{"issue":"26","key":"10.1016\/j.ejso.2023.07.004_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.21105\/joss.00772","article-title":"Ggeffects: tidy data frames of marginal effects from regression models","volume":"3","author":"L\u00fcdecke","year":"2018","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.ejso.2023.07.004_bib34","series-title":"R: a language and environment for statistical computing","year":"2022"},{"key":"10.1016\/j.ejso.2023.07.004_bib35","series-title":"Interactive web-based data visualization with r, plotly, and shiny","author":"Sievert","year":"2020"},{"key":"10.1016\/j.ejso.2023.07.004_bib36","author":"Wickham"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.004_bib37","first-page":"7","article-title":"Diagnostic checking in regression relationships","volume":"2","author":"Zeileis","year":"2002","journal-title":"R\u00a0News"},{"key":"10.1016\/j.ejso.2023.07.004_bib38","author":"Klinke"},{"issue":"6","key":"10.1016\/j.ejso.2023.07.004_bib39","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/bimj.202000181","article-title":"Optimal dose-finding for efficacy-safety models","volume":"63","author":"Tsirpitzi","year":"2021","journal-title":"Biom J"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:36:04Z","timestamp":1782884164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323005711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0748798323005711"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.07.004","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I\/II controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106978"}}